Med Ed 101
DECEMBER 1, 2024
I hope everyone had a Happy Thanksgiving! It’s my turn to give back to all of you! We’ve got something for everyone looking to learn more about medications or preparing for board exams! Pharmacist Board Certification – 25% Off! Use this discount code at checkout: Board25 BCPS Study Materials NAPLEX Study Materials BCMTMS Study Materials […] The post Cyber Monday/Black Friday Discounts!
Express Pharma
DECEMBER 1, 2024
The Maharashtra Government has appointed Rajesh Janardhan Narvekar as the new Commissioner of the Food and Drug Administration (FDA), Maharashtra. His appointment follows the retirement of former FDA Commissioner Abhimanyu Kale. Narvekar, a 2009 batch Indian Administrative Service (IAS) officer, holds a Master’s degree in History and has extensive administrative experience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Compounding Pharmacy of America
DECEMBER 1, 2024
Learn how Testosterone Replacement Therapy (TRT) can enhance energy, mood, and overall health in women. Discover signs of low testosterone, TRT benefits, and natural hormone support. The post Why Do Women Need Testosterone? appeared first on The Compounding Pharmacy of America.
EMCrit Project
DECEMBER 1, 2024
John Holcomb, author of the PROPPR trial, on massive transfusion in 2024 EMCrit Project by Scott Weingart, MD FCCM.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
DECEMBER 1, 2024
The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive treatment.
Express Pharma
DECEMBER 1, 2024
Biocon Biologics, a global biosimilars company and subsidiary of Biocon, has announced that the U.S. Food and Drug Administration (FDA) has approved YESINTEK (Ustekinumab-kfce). The biosimilar is a monoclonal antibody designed to treat Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. The company had previously informed the Stock Exchange on 29 February 2024 about its settlement and licensing agreement with Janssen Biotech, Janssen Sciences Ireland, and Johnson &
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmaceutical Commerce
DECEMBER 1, 2024
Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
Pharmacy Joe
DECEMBER 1, 2024
In this episode, I’ll discuss why the CAP guidelines do not recommend treating most cases of suspected aspiration pneumonia with broadening antibiotic therapy. Episode 979: Does aspiration pneumonia require different antibiotics than community acquired pneumonia? Subscribe on iTunes , Android , or Stitcher Broadening therapy in community-acquired pneumonia to cover potential anaerobes in the case of suspected aspiration pneumonia is a common occurrence.
Pharmacy Times
DECEMBER 1, 2024
Treatment for RLS includes lifestyle modifications, medication, and in some cases, non-drug therapies, aiming to reduce symptoms and improve sleep and daytime functioning.
Expert insights. Personalized for you.
110 
Let's personalize your content